Clinical Trial

Air Pollution and Cardiovascular Disease in Qatar: an Interventional Study to Reduce Blood Pressure

Study acronym: APCIQ-BP
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 20, 2025 (before its estimated April 2026 completion). Its status may not reflect the trial's current state.
Summary
The main objective is to determine if in-home portable air cleaners provide persistent reductions in PM2.5 exposures and improvements in systolic blood pressure and biochemical parameters over 4-weeks in patients with metabolic syndrome residing in Qatar.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2023-06-05; most recent amendment 2025-07-16.
Trial Details
NCT Number NCT05903950
Lead Sponsor Weill Cornell Medical College in Qatar
Collaborators: Hamad Medical Corporation, Case Western Reserve University
Conditions Hypertension, Systolic, Metabolic Syndrome
Enrollment 100 participants
Start Date 2024-11-03
Primary Completion 2026-04 (estimated)
Study Completion 2026-04 (estimated)
Updated on ClinicalTrials.gov 2025-07-20